There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Structure of SEW2871
CAS No.: 256414-75-2
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
SEW2871 is a potent and selective sphingosine-1-phosphate 1 (S1P1) receptor agonist. Activates S1P1 receptor with an EC50 of 13 nM, but does not activate S1P2, S1P3, S1P4 or S1P5 receptors at concentrations up to 10 μM. Cell-permeable and active in vivo.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 256414-75-2 |
Formula : | C20H10F6N2OS |
M.W : | 440.36 |
SMILES Code : | FC(C1=CC(C2=NOC(C3=CC(C4=CC=CC=C4)=C(C(F)(F)F)S3)=N2)=CC=C1)(F)F |
MDL No. : | MFCD00096600 |
InChI Key : | OYMNPJXKQVTQTR-UHFFFAOYSA-N |
Pubchem ID : | 4077460 |
GHS Pictogram: |
![]() |
Signal Word: | Danger |
Hazard Statements: | H300 |
Precautionary Statements: | P264-P301+P310 |
Class: | 6.1 |
UN#: | 2811 |
Packing Group: | Ⅲ |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Human mature oligodendrocytes | 100 nM | 2 days | Induced membrane elaboration | Am J Pathol. 2008 Oct;173(4):1143-52 |
Human ILC3 | 1 µM | 2-3 days | Inhibited production of GM-CSF, IL-22, and IL-17 | Front Immunol. 2019 Feb 13;10:217 |
Rat sensory neurons | 100 nM | 10 min | To evaluate the effect of SEW2871 on the excitability of rat sensory neurons, results showed that SEW2871 significantly increased the firing frequency of action potentials. | J Neuroinflammation. 2015 Apr 12;12:70 |
CeL-Sst neurons (Type B) | 100 nM | 10 minutes | SEW2871 significantly depolarized the resting membrane potential and increased input resistance of Type B neurons, but did not change firing frequency. | Neuropharmacology. 2022 Feb 1;203:108885 |
CeL-Sst neurons (Type A) | 100 nM | 10 minutes | SEW2871 did not significantly alter the resting membrane potential or firing frequency of Type A neurons. | Neuropharmacology. 2022 Feb 1;203:108885 |
Immortalized mouse podocytes | 1 µM | 14 days | SEW2871 significantly reduced TNF-α and VEGF mRNA expression in podocytes under high glucose conditions. | Kidney Int. 2011 May;79(10):1090-8 |
Mouse peritoneal macrophages | 1 µM | 30 minutes | SEW2871 stimulates the interaction between SR-B1 and S1PR1-eGFP, similar to HDL, and this interaction was blocked by an inhibitor of SR-B1’s lipid transport activity or an SR-B1 blocking antibody. | J Lipid Res. 2024 May;65(5):100541 |
HEK293A-S1P1-GFP cells | 5 µM | 30 minutes | To evaluate the effect of SEW2871 on S1PR1 internalization. Results showed SEW2871 significantly promoted S1PR1 internalization, which could be blocked by S1PR1 antagonist W146. | Cancer Lett. 2021 May 28;506:107-119 |
Human umbilical vein endothelial cells (HUVEC) | 5 µM | 30 minutes | To evaluate the inhibitory effect of SEW2871 on inflammatory mediator-induced endothelial gap formation. Results showed SEW2871 effectively inhibited BK, VEGF and IL-8 induced endothelial gap formation. | Cancer Lett. 2021 May 28;506:107-119 |
C57BL/6J peritoneal macrophages | 1 µM | 4 hours | SEW2871 significantly reduced LPS-mediated iNOS activity and TNF α secretion and increased Arg I activity, suggesting that the antiinflammatory effects of S1P in macrophages are mediated by the S1P1 receptor. | Circ Res. 2008 Apr 25;102(8):950-8 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Rats | Streptozotocin-induced diabetic nephropathy model | Intraperitoneal injection | 0.1 mg/kg | Monday to Friday, for 9 weeks | SEW2871 significantly reduced urinary albumin excretion and TNF-α levels in diabetic rats, and improved tubular injury and podocyte-specific protein expression. | Kidney Int. 2011 May;79(10):1090-8 |
Rats | Thermal hyperalgesia model | Intraplantar injection | 0.3 μg | Single injection, sustained for 5 hours | SEW2871 induces thermal hyperalgesia via activation of S1P1 receptor, which can be blocked by the S1P1 receptor antagonist W146 | Pain. 2011 Mar;152(3):643-648 |
Spontaneously hypertensive stroke-prone rats (SHRSP) | Unilateral carotid artery occlusion (UCAO) and Japanese permissive diet (JPD) model | Intraperitoneal injection | 0.5 mg/kg | Every other day for 4 weeks | SEW2871 significantly reduced lesions in both white and grey matter and ameliorated cerebral blood flow. SEW2871 reversed the loss of endothelial S1PR 1 and tight junction proteins, and significantly attenuated UCAO/JPD induced accumulation of neuronal phosphorylated tau. | Aging Dis. 2024 May 21;16(2):1099-1119 |
Rats | Benign prostatic hyperplasia model | Intraprostatic injection | 0.5 nmol | Single injection, duration of 4 weeks | SEW2871 led to prostate enlargement in rats | iScience. 2024 Oct 30;27(12):111290 |
Mice | ApoM-deficient mice | Intraperitoneal injection | 10 mg/g | Single injection, 150 min prior to imaging | SEW2871 rapidly normalized paracellular BBB permeability in Apom-/- mice, and inhibited transcytosis in penetrating arterioles, but not in pial arterioles. | Elife. 2019 Nov 25;8:e49405 |
C57BL/6J mice | Epilepsy model | Intraperitoneal injection | 10 mg/kg | Once a day for 48 hours | SEW2871 decreased the level of tight junction protein in the hippocampus of epileptic mice, increased blood-brain barrier leakage, and aggravated the severity of seizures compared with the control. | Neural Regen Res. 2023 Aug;18(8):1763-1769 |
Mice | Partial hepatectomy (PH) model and bile duct ligation (BDL) model | Oral gavage | 10 mg/kg/day | Once daily for 7 days | SEW2871 promotes liver regeneration and alleviates fibrosis by activating endothelial S1P1 signaling. In Apom-/- mice, SEW2871 enhanced the restoration of liver weight, prolonged animal survival, and improved hepatic function recovery. Additionally, SEW2871 reduced fibrosis and thrombosis. | Cancer Med. 2020 Oct;9(19):7125-7136 |
Mice | Partial hepatectomy (PH) model and bile duct ligation (BDL) model | Oral gavage | 10 mg/kg/day | Once daily for 7 days | SEW2871 promotes liver regeneration and alleviates fibrosis by activating endothelial S1P1 signaling. In Apom-/- mice, SEW2871 enhanced the restoration of liver weight, prolonged animal survival, and improved hepatic function recovery. Additionally, SEW2871 reduced fibrosis and thrombosis. | JCI Insight. 2016 Dec 22;1(21):e87058 |
C57BL/6J male mice | Chronic migraine model | Intraperitoneal injection | 20 mg/kg | Once daily for 9 days | SEW2871 did not attenuate thermal and mechanical allodynia caused by repeated NTG administration | J Headache Pain. 2022 Feb 10;23(1):25 |
C57BL/6 mice | VEGFR blockade-induced emphysema model | Gavage | 20 mg/kg | Once daily for 5 days | To evaluate the protective effect of SEW2871 on VEGFR blockade-induced airspace enlargement. Results showed that SEW2871 significantly inhibited airspace enlargement and reduced lung apoptosis. | Am J Respir Crit Care Med. 2010 Feb 15;181(4):344-52 |
Mice | Repeated hapten application-induced cutaneous response model | Gavage | 20 mg/kg | Single administration | SEW2871 decreased the number of skin-infiltrating eosinophils and reduced the late-phase reaction. | Am J Pathol. 2010 Oct;177(4):1881-7 |
Mice | Transverse Aortic Constriction (TAC) model | Intraperitoneal injection | 3 mg/kg | 1 hour before surgery and every 12 hours thereafter for 72 hours | To evaluate the protective effects of SEW2871 on cardiac inflammation and function, results showed SEW2871 significantly reduced myocardial inflammation and preserved cardiac function. | JCI Insight. 2016 Apr 21;1(5):e85484 |
Mice | CX3CR1-EGFP knock-in mice and CSF1R-EGFP transgenic mice | Intravenous injection | 5 mg/kg | Single dose | To evaluate the effect of SEW2871 on monocyte migration in bone tissues, showing that SEW2871 significantly increased the motility of CX3CR1-EGFP positive cells. | Nature. 2009 Mar 26;458(7237):524-8 |
Athymic Foxn1nu nude mice | Melanoma lung metastasis model | Intraperitoneal injection | 5 mg/kg | Single dose, 6, 12 or 18 hours before | To evaluate the inhibitory effect of SEW2871 on melanoma lung metastasis. Results showed SEW2871 treatment reduced lung metastatic nodules by 65-80%. | Cancer Lett. 2021 May 28;506:107-119 |
Rats | Transient middle cerebral artery occlusion model | Intraperitoneal injection | 5mg/kg | Single dose immediately after reperfusion | To evaluate the neuroprotective effect of SEW2871 on cerebral ischemia, results showed that SEW2871 significantly reduced infarct volume and improved neurological score | Stroke. 2010 Feb;41(2):368-74 |
Tags: SEW2871 | LPL Receptor | ERK | Akt | Lysophospholipid Receptor | Extracellular signal regulated kinases | PKB | Protein kinase B | Crohn's disease | colitis | Alzheimer's disease | liver fibrosis active | diabetes | ischaemia-reperfusion injury | inhibitor | 256414-75-2 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL